A patient with myasthenia gravis and a thymoma did not respond to thym
ectomy. He was submitted to radiotherapy concurrent with steroid thera
py followed by an alkylating based chemotherapy Four years later, he d
eveloped an otherwise typical Philadelphia chromosome/BCR-ABL positive
chronic myelogenous leukemia (CML) that quickly evolved to a blast cr
isis. We discuss the possible cause-effect mechanism between the previ
ous treatment and CML, and suggest that a distinct mechanism, albeit u
nknown, could be involved in the development and progression of second
ary CML.